|Articles|February 1, 2009
- Volume 0 0
7 Deadly Sins: R?sum?
Advertisement
- Spelling errors—Proof, reproof, and have at least 2 reviewers proof your r?sum?.
- Dirty/unclear print—Print in traditional fonts with a size of at least 12 points, using a laser printer.
- Poor quality paper—Purchase a high-grade, heavy bonded paper.
- Weak career objective—Write an objective that is "employer-oriented" and not purely self-serving.
- No cover letter—Attach a cover letter that introduces you and your interest in the position.
- Extraneous marks, folds, wrinkles, tears—Keep your r?sum?s in a firm, closed folder.
- Impersonal mailing address—Send your r?sum? to the individual who will make the hiring decision?not to the company or "to whom it may concern."
Articles in this issue
almost 17 years ago
Dr. Tom's Top 10 Tips: Passing the Pharmacy Boardsalmost 17 years ago
The Next Generation of Pharmacy Practicealmost 17 years ago
Endless Opportunities in the Pharmaceutical Industryalmost 17 years ago
Q&A: Perspective from a Specialty Pharmacy Veteranalmost 17 years ago
Career Connectionsalmost 17 years ago
Behind the Bench: Inside Kmart's Pharmacy Servicealmost 17 years ago
Mayo's Diversity of Practice Appealing to Pharmacistsalmost 17 years ago
VA: Rewarding Opportunities and Room to Growalmost 17 years ago
Pharmacists Empowered at Supermarket Chainsalmost 17 years ago
7 Deadly Sins: InterviewsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5
